All Activity

Illinois officials have published guidance for marijuana businesses about a new law that doubles the amount of marijuana that adults can legally possess, allows drive-thrus and curbside pickups at dispensaries and lets them stay open for longer hours of operation, among other changes. The reforms are part of a large-scale cannabis omnibus bill that Gov. JB Pritzker (D) signed into law last month. The Illinois Department of Financial and Professional Regulation (IDFPR), which regulates adult-use and medical cannabis dispensaries, published the five-page explanation of some of the key changes included in the legislation that dispensaries need to know about. “Dispensaries may begin offering curbside pick-up and drive-through services. However, prior to offering drive-through or curbside, licensees need to have their systems reviewed and approved by IDFPR,” it says. “Dispensaries may expand their hours of operations to 2am with local municipal approval.” As enacted into law, SB 3222 allows residents of the state who are over 21 years of age to possess up to 60 grams of marijuana flower—double the amount in prior law. They are also able to have up to 10 grams of cannabis concentrates and infused products with up to 1,000 mg of THC—also double the earlier limit. Possession amounts for adult non-residents are also doubled under the bill and are generally set at half of what residents can carry.. “Additionally, registered medical patients in Illinois are authorized to purchase seeds from licensed dispensaries,” IDFPR said. Among other changes that IDFPR flagged are that: The specific dispensary name is no longer required to be included on cannabis products prior to sale. Dispensaries are no longer required to contract with third party security companies, and instead may hire their own security guards. Dispensaries may begin storing sixty (60) days of security footage rather than ninety (90) days. Agents, agents-in-charge, and principal officers who previously were barred from holding a medical cannabis license solely due to a criminal conviction referred to as an “excluded offense” are no longer barred from holding such license. This is also true of future applicants. Most of the changes in the legislation took effect immediately, but the IDFPR guidance notes that a provision allowing all licensed dispensaries to opt-in for medical licenses will go into force on September 10. “Any adult use dispensary holding an active license in good standing may opt-in for a medical dispensary license,” it said. “This medical dispensary license will allow the dispensary to sell cannabis to medical cannabis patients at the medical tax rate up to the medical patient’s allotment.” Also as of September 10, “all cannabis products sold to medical cannabis patients must contain a federally mandated warning label,” IDFPR said. “This label must be applied prior to the sale to the patient and dispensaries are responsible for ensuring the label is properly affixed to the product.” The agency also noted the loosening of requirements for dispensary employee badges and on marijuana business ownership limits. “This fact sheet is informational only, non-exhaustive, and should not be construed as legal advice, administrative rulemaking, or making binding statements of law,” the guidance, which was first reported by Illinois New Joint, says. “The Department of Financial and Professional Regulation recommends all licensees coordinate with their own legal counsel and comprehensively review all relevant laws and regulations to ensure continued compliance.” IDFPR noted that many of the new changes may require updates to the state’s seed-to-sale tracking system, adding that it is considering hosting a potential town hall meeting on the changes and is “reviewing its existing administrative rules and anticipates proposing any rules needed because of SB 3222 through the formal rulemaking process in the coming months.” The new law also contains a number of cannabis policy updates that don’t directly impact dispensary operations and weren’t noted in the IDFPR guidance. For example, people with past convictions for possession of up to 60 grams of marijuana will now be able to have those records expunged—double the previous cutoff allowing only those with convictions for up to 30 grams to be eligible. The legislation also recriminalizes hemp THC products with more than 0.4 milligrams of THC per container, in line with a federal ban that is set to take effect in November. The state’s list of medical marijuana qualifying conditions is also being expanded to add female orgasmic disorder, endometriosis, ovarian cysts and uterine fibroids. The governor held a signing ceremony for the legislation at a marijuana dispensary, saying he is “proud that Illinois continues to lead the nation in showing what thoughtful, balanced cannabis policy can achieve.” In 2019, Pritzker signed the state’s initial marijuana legalization policy into law. The post Illinois Officials Update Marijuana Dispensaries On Increased Possession Limits And Ability To Add Drive-Thru Windows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“I don’t think the industry can survive this. I think [what] you’re going to see over the next couple years is a major contraction to where there’s just a few people surviving.” By Jake Thomas, Oregon Capital Chronicle State regulators are seeking steep fee hikes on Oregon’s nascent psilocybin industry, a move that critics say would push the already high price tag of a legal mushroom trip even higher while causing more businesses to close. The Oregon Health Authority in late June announced proposed fee increases that would affect virtually every corner of the industry, aiming to financially sustain the groundbreaking program. Among the biggest changes would be doubling annual license fees from $10,000 to $20,000 for psilocybin manufacturers and service centers where adults 21 and older take supervised trips. The potential fee increases come after a wave of service center closures, raising doubts about the viability of Oregon’s legal psilocybin experiment that voters approved in 2020. The state has issued licenses to 39 service centers, about half of which have expired or been surrendered, according to state figures. “I don’t think the industry can survive this,” said Ryan Reid, the co-founder and operations director of Bendable Therapy, a Bend-based service center. “I think [what] you’re going to see over the next couple years is a major contraction to where there’s just a few people surviving.” Oregon’s psilocybin program is not supported by taxpayer money and is instead funded through fees, health authority spokesperson Erica Heartquist said in an email. Because revenue has not kept up with rising costs, she continued, “the only option is increasing fees” despite the program’s cost-saving efforts. Heidi Pendergast, Oregon director of the Healing Advocacy Fund, which advocates for psilocybin access, called the proposed fee increases “unprecedented” and out of line with other licensing costs for the cannabis businesses and health-oriented professions. An individual psilocybin session can cost between $850 and $3,000, which has meant clients have skewed white and wealthier. Pendergast said she anticipates clients would see higher costs from the fee increases, which would mostly take effect next year. The uncertainty comes as psilocybin continues gaining acceptance as a mental health treatment and as the state has opened the door to integrating it with the medical system. Pendergast described the program as safe, noting that just a sliver of the estimated 22,000 people who have used legal psilocybin have reported adverse events since service centers opened in 2023. “This program really deserves to be part of the behavioral health framework in this country,” she said. One licensed lab As the head of Rose City Laboratories, Daniel Huson oversees Oregon’s only licensed and accredited psilocybin testing laboratory. Despite being a linchpin in the state’s psilocybin system, he said the $26,000 his lab made last year from compliance testing didn’t cover all of its costs, including the $10,000 annual licensing fee. Huson continued offering the testing because he’s passionate about how psilocybin can positively change people’s lives. Regulators are seeking to double the annual laboratory licensing fee starting January 2029, later than the other hikes. Since the lab began testing psilocybin in 2023, Huson said he’s increased the cost of a compliance test from $250 to $600, which he expects to rise further. Without a regulatory change of course, he said the industry may not be viable over the next two years and his lab will stop offering psilocybin testing in 2029, potentially leaving the state without a psilocybin testing lab. “There’s no incentive to be a testing laboratory because it’s expensive,” he said. “And they’re going to be in trouble.” No more discounts The proposed changes would also eliminate reduced fees for nonprofits, veterans and low-income people. Currently, each pays half the annual fee for a manufacturer or service center license. If regulators’ proposed changes take effect, those license holders would see their licensing fees quadruple to $20,000. Nearly a third of Oregon’s roughly 400 psilocybin-related licenses qualify for a reduced fee, according to the health authority’s Heartquist. As a nonprofit service center, Bendable Therapy is focused on accessibility over its margins, said Reid, one of its co-founders. The elimination of reduced fees, he said, would mean increased costs for clients and less money for scholarships to make its services more affordable. “This is a tight industry, and we’ve done a good job surviving,” he said. “But this is just going to make it that much harder and just really increase the costs and reduce access for our customers.” Facilitators, who guide clients through psilocybin sessions, would see their annual licensing fees double to $4,000—with discounts for veterans and low-income applicants eliminated. They typically work part-time as contractors. Reid said his center will subsidize the licensing costs of the centers’ six facilitators. Plus, regulators’ changes would increase the cost of a permit needed to work in a center from $25 to $200. In total, he expects licensing costs to increase by as much as $50,000. Campaign promise The ballot initiative campaign that legalized psilocybin in Oregon promised to make the life-altering substance safe, accessible and affordable—without ongoing costs to taxpayers after a startup period. However, a health authority budget document states the industry’s slow growth has meant it hasn’t generated enough license fees to cover the program’s cost. The authority blamed local restrictions on psilocybin-related businesses, as well as challenges getting banking and insurance for an industry centered on a federally illegal drug. It also blamed unexpected administrative costs. Pendergast, of the Healing Advocacy Fund, said it’s common for new programs to require additional funding before they are self-sustaining and called for more budget transparency before the fees increase. “This is really a matter of how we are right-sizing regulation for this program,” she said. Dr. Eric Lee started Space Psychedelic Clinic in 2024 on what he called a “shoestring” budget in “not a gorgeous location” in Portland that allows him to charge $925 for an individual session. He expects to weather the fee increase and plans to move into a larger building to accommodate demand. But he doesn’t think other centers will survive and wants other states considering legal psilocybin to take note of what’s happening in Oregon. “There is a vast segment of the population that will just never be able to use legal psychedelics because of the price point,” he said, adding, “I don’t think people want that from this law, and I think it’s a huge part of why the business is failing.” This story was first published by Oregon Capital Chronicle. The post Oregon Officials Propose Major Fee Hike For Psilocybin Businesses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A federal agency has published a new report that aims to assist state marijuana officials in developing standards for scales used in the sale of cannabis products. The 31-page document, published late last month by the National Institute of Standards and Technology (NIST), notes that “with the legalization of Cannabis in many States, the suitability of the scales used in the sale of Cannabis products becomes increasingly important.” “Cannabis products are unique in that they have distinct properties from traditional commodities that are subject to weights and measures regulations, such as grocery products, precious metals, and gems,” it says. The report details what NIST believes to be the five most relevant aspects of scales involved in marijuana sales. “These scale characteristics include the accuracy classification, the value of the verification scale interval, the monetary value per scale division, auxiliary indication, and the minimum capacity and recommended minimum load,” it says. When it comes to accuracy classification, the NIST report notes that while it may be reasonable to conclude that scales used for marijuana should be of accuracy Class II because cannabis products “are high-value commodities like precious metals and gems,” the effect of air buoyancy and varying moisture levels “may not justify” the use such high-precision instruments with strict error margins. “Jurisdictions should consider this duality when determining the proper accuracy class for scales used in the sale of Cannabis products,” it says. With respect to monetary value per scale division, NIST says its handbook currently has no requirement on the topic. “If desired, such a requirement could be implemented as a User Requirement for all commodities (or all high-value commodities) to avoid being arbitrary towards Cannabis products,” the report says. For auxiliary indications, which allow higher resolution digits for more precise weighing, NIST said it is a “useful feature that extends the weighing range at the low end” but that it could potentially confuse some consumers. The value of the verification scale interval, minimum capacity and recommended minimum load are interrelated, the report explains. “The recommended minimum load (or minimum capacity) implicitly sets an upper limit on the verification scale interval,” it says. “A separate requirement for a maximum value of the verification scale interval, applied only to scales used for the sale of Cannabis products, appears arbitrary (since there is no such requirement for other high-value commodities in NIST Handbook 44). It also undermines the purpose of the recommended minimum load requirement.” While NIST stresses in the report that it does not promote specific recommendations for states when it comes to requirements for scales used to measure cannabis, its analysis is meant to provide “objective information” that regulators can use to act on the issue. “These conclusions are intended to clarify the discussion and help regulators and other stakeholders develop a set of requirements for scales used in the sale of Cannabis products, based on scientific analysis.” To reach the report’s conclusions, NIST officials examined “real-world data” on scales that are being used to weigh cannabis in nine states. The new document represents the latest in a series of cannabis-related projects for the federal agency. Last month NIST announced that it added dozens of new marijuana components to an official government library of compounds that is used to help identify unknown substances in food, drugs, cosmetics, the environment, body fluids and forensic evidence. In 2025, NIST hosted a workshop aimed at facilitating “an open and candid discussion” about the development and implementation of technology to test a person’s breath for marijuana impairment. Also last year, researchers with the agency said they made the first-ever detection of THC in human breath following the consumption of infused edibles—a possible step forward in terms of field testing for cannabis impairment. NIST has also published a series of reports as part of a project called the Cannabis Laboratory Quality Assurance Program (CannaQAP). Meanwhile, NIST has made a series of updates to an industry standardization handbook it publishes as a result of cannabis-related stances adopted by the National Conference of Weights and Measures. The post New Federal Report Analyzes Scales Used To Weigh Marijuana, Offering Advice For State Officials appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A new survey shows that more than three out of four people who consume THC-infused cannabis beverages drink less alcohol—with more than a fifth saying they have quit alcohol entirely. The poll, published on Tuesday, was conducted by THC beverage company Crescent Canna, which surveyed its customers about their use of THC drinks. Since first trying the products, 37 percent said they drink much less alcohol, 19 percent drink slightly less and 21 percent have quit alcohol altogether. Forty-four percent said that THC beverages have become part of their regular wellness routine. When asked more specifically why they like cannabis drinks, 80 percent said the products help them relax or unwind and 50 percent said they use them as a sleep aid. More than half (51 percent) said THC beverages help them to avoid the negative effect of alcohol, and 60 percent said there is no hangover. Via Crescent Canna. More than a third of THC drink consumers (35 percent) said they end up using other cannabis products less often due to the availability of the beverages. Another 15 percent said they exclusively consume cannabis in drink form. Consumers, meanwhile, are broadly aware of the looming federal recriminalization of hemp-derived THC products that is set to take effect in November, with 87 percent saying they know about the planned ban. Twenty-seven percent said they are either actively stocking up on THC drinks or buying them more often in preparation for the federal crackdown, and another 41 percent said they plan to as November approaches. If the ban goes into effect as scheduled, 67 percent of THC drink consumers said they would turn to other forms of cannabis and 23 percent would start drinking more alcohol. Just 8 percent say they would stop using THC entirely. For now, the vast majority of consumers (63 percent) say they are buying cannabis drinks online, while another 26 percent say they obtain them at grocery, liquor, convenience or specialty retail stores. Five percent get THC drinks at marijuana dispensaries and another 5 percent buy them at bars, restaurants or event venues. The poll involved interviews between May 29 and June 11 with 1,637 adults over the age of 21 who have tried a THC beverage at least once. An earlier poll conducted by Crescent Canna last year similarly showed that nearly four in five adults who drink cannabis-infused beverages say they’ve reduced their alcohol intake—and more than a fifth have quit drinking alcohol altogether. A separate recent survey from cannabis telehealth platform NuggMD found that marijuana consumers shows they are overwhelmingly more likely to want to dine at restaurants that offer cannabis-derived THC drinks as an alternative to alcohol. A previous NuggMD poll found that cannabis consumers are more likely to shop at Target following the major retailer’s decision to start selling hemp-derived THC drinks, The latest poll results on consumer preferences come as lawmakers from both major parties have filed various pieces of legislation to delay, alter or reverse the impending federal recriminalization of hemp THC products and as the White House pushes Congress to act on the issue. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, he signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. In a letter to House Speaker Mike Johnson (R-LA) last month, White House Office of Management and Budget (OMB) Director Russell Vought said the administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing legislation that would keep many hemp products legal that are currently set to be recriminalized this year, add labeling requirements and institute new taxes on sales, among other regulatory reforms. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said last month, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” The call to avert a broad prohibition on hemp CBD products was included in a statement of administration policy about an annual agriculture spending bill that passed the House of Representatives. Several lawmakers had filed amendments to that legislation to keep hemp products legal, but each was either blocked by the House Rules Committee from advancing to a floor vote or withdrawn by its sponsor. “The Administration supports advancement of this legislation, but looks forward to addressing its concerns prior to enactment,” OMB said in its statement of administration policy. “The Administration looks forward to working with the Congress to provide more input as the bill’s legislative process unfolds.” In April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post on the same day his administration announced it is moving forward with rescheduling marijuana. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” It’s not clear how far Trump wants to scale back the scope of the scheduled federal restrictions on hemp products and what kinds of revised THC rules and limitations he would prefer to sign into law. As Marijuana Moment reported last month, a Republican congresswoman is circulating draft legislation that would keep hemp THC beverages legal under federal law, creating a carve-out from the broad recriminalization of products derived from the crop that is set to take effect later this year. The Hemp-Derived Beverage Regulatory Clarity Act from Rep. Beth Van Duyne (R-TX), in its current form, would allow adults over 21 to purchase and consume hemp THC drinks with up to 5 milligrams of delta-9 THC per serving. It would also impose a federal tax of 10 cents per milligram of any hemp-derived cannabinoid contained within such beverages. The National Restaurant Association, which represents the industry, recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages that is scheduled to take effect later this year and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. A U.S. Department of Agriculture report published in April shows that farmers in the U.S. grew three-quarters of a billion dollars worth of hemp crops in 2025—a 64 percent increase from the prior year. The post THC-Infused Cannabis Beverages Are Helping People Quit Drinking Alcohol, Survey Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Excellent post. I was always checking this blog, and I’m impressed! Extremely useful info specially the last part, I care for such information a lot. I was exploring this particular info for a long time. Thanks to this blog my exploration has ended. agen toto

Excellent post. I was always checking this blog, and I’m impressed! Extremely useful info specially the last part, I care for such information a lot. I was exploring this particular info for a long time. Thanks to this blog my exploration has ended. bmw777 login

Tired of spending your evenings alone in Delhi's bustling surroundings? It's time to change that! Our agency is known for its reliability, discretion, and top-notch service. Our Delhi Escort service offers you a chance to meet some of the most beautiful and exciting women in the capital. Whether you're looking for a quick fling or a long, passionate night, our girls are ready to deliver. With 1500+ profiles to choose from, including college girls, models, and housewives, we have something for everyone. Book now and get free delivery within 30 minutes. Your perfect evening in Delhi starts here. Lutyens Escort || Escort in Maharani Bagh || Malviya Nagar Escort Service || Escort Service Bengali Market || Escort Service in Mandi House ||

Some truly wonderful work on behalf of the owner of this internet site , perfectly great articles . bmw777

Marijuana regulators in Virginia are conducting a survey to gather input from the public and stakeholders as they work to implement the state’s newly enacted law legalizing recreational cannabis sales. The Virginia Cannabis Control Authority (CCA), which currently oversees medical cannabis and under the new law will also regulate adult-use marijuana and hemp, said the survey “is designed to bring real-world insight from people and organizations who are part of, or impacted by, Virginia’s evolving cannabis market.” “Feedback collected will help the CCA better understand a range of perspectives and will inform ongoing planning and decision-making as it considers future regulations,” CCA said. Respondents are given an open-ended field to enter in comments after choosing a broad topic area, including: Fees and Retail License Applications License, Permits, and Registrations (e.g., impact and microbusiness) Security: Facility and Personnel Advertising, Transportation, and Other Regulated Operations Labeling and Packaging Cannabis Products Regulated Product Testing Compliance and Enforcement (Related to licenses and sales) Regulated Hemp Products Public Health & Safety Other “This is about making sure we hear directly from the people who are closest to the work and the impacts,” Jamie Patten, the acting head and chief administrative officer of CCA, said in a press release. “Stakeholder feedback is an important part of our process as we work to develop regulations that protect public safety, advance public health, and support a well-regulated cannabis market.” Your voice matters. The CCA is seeking feedback on future cannabis regulations through a new survey. Share your perspective to help inform the CCA of potential regulation impacts. Fill out the form: https://t.co/evY70cBqdh pic.twitter.com/7kyfHHa4BH — Virginia Cannabis Control Authority (@Virginia_CCA) June 30, 2026 “Your input will enable the CCA to consider how any future regulations may impact varying stakeholders,” the form says. “We value all input and while the CCA cannot implement every suggestion, we are tracking all ideas for the future.” The survey is available through July 21. CCA separately posted a brief explainer of the key provisions of the state’s newly enacted marijuana laws. New marijuana and hemp laws are coming to Virginia. Wondering what changes, when they take effect, and what they mean? We've broken it all down in one place. Read the overview: https://t.co/zAUYDub1Kt@VaAgriculture — Virginia Cannabis Control Authority (@Virginia_CCA) July 1, 2026 Late last month, the Virginia Senate and House of Delegates adopted Gov. Abigail Spanberger’s (D) proposed amendments to budget legislation containing provisions to legalize recreational cannabis sales that they had given initial approval to previously. Because lawmakers accepted her suggested changes in full, the measure was immediately formally enacted into law and didn’t require any further action from the governor. Spanberger in May vetoed a previous measure to legalize recreational cannabis sales after lawmakers rejected her proposed amendments to the plan. She later negotiated with Sen. Lashrecse Aird (D) and Del. Paul Krizek (D), who sponsored the earlier measure, on a compromise deal that was included in the budget legislation that passed. The new plan differs significantly in several ways from the earlier legislation. For example, it sets the launch date for recreational marijuana sales at July 1, 2027, which is what Spanberger proposed in contrast to the January 1 date in what lawmakers had passed. It also sets the legal public marijuana possession and per-transaction purchase limit at 2 ounces, an increase from the current legal limit of one ounce. The legislation lawmakers passed earlier this year would have allowed adults to possess up to 2.5 ounces. The bill also cedes to Spanberger on language to increase a marijuana excise tax from 6 percent to 8 percent after two years of legal sales. By way of compromise, the new agreement will make public consumption of marijuana punishable by a civil penalty of $250—a significant increase from the $25 in current law but less harsh than the class 4 criminal misdemeanor the governor sought in her proposed changes to the previous bill. Lawmakers passed the initial cannabis sales bills in March, but the governor then suggested changes to the legalization proposal—including delaying the start date for sales by six months, increasing taxes and instituting new criminal penalties for cannabis consumers. The legislature in April declined to take up the amendments during a one-day reconvened session, however, effectively rejecting them. Spanberger then issued a veto. Spanberger said in June that she was having “really productive” and “incredible” conversations with lawmakers about crafting a compromise approach to legalizing adult-use cannabis sales, and Marijuana Moment previously reported on the ongoing talks. The governor, meanwhile, has tried to publicly explain her veto—including by saying it is her view that “taking a little bit longer” to launch the market is not something she sees as “negative” because it is more important to get the details right than to do it fast. A recent survey found that bipartisan majorities of Virginia voters wanted Spanberger to sign the cannabis legislation into law, and that they specifically disagreed with her desire to slow the launch timeline for legal sales. The governor recently acknowledged in a separate interview that “a lot of people are not pleased” with her veto of the cannabis legislation. “Friends and family are displeased as well,” she said. Spanberger has repeatedly responded to criticism of her cannabis amendments from the bill sponsors and advocates by saying the suggested changes came after she spoke to the leaders of other states that have already implemented adult-use marijuana markets. A spokesperson for Spanberger declined to name any other governors she talked to about cannabis in response to a question from Marijuana Moment, however. The governor separately sought to explain her veto in an earlier interview, reiterating that she supports launching a legal cannabis market but worried about what she called a “rushed timeline” and “far more stores across Virginia” than she thinks are appropriate. Personal marijuana possession and home cultivation of marijuana has been legal in Virginia since 2021, but then-Gov. Glenn Youngkin (R) twice vetoed bills to provide consumers with a way to legally purchase regulated adult-use cannabis. Here are the key details of the new cannabis plan in the budget and how it compares to legislation that Spanberger vetoed—SB 542 and HB 642—as well as her previously proposed amendments to those measures: Adults will be able to purchase up to 2 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. That will represent an increase from the limit in current law of 1 ounce. Lawmakers previously proposed setting the amount at 2.5 ounces and the governor only wanted 2 ounces. Legal sales can begin on July 1, 2027. Lawmakers previously set the date for January 1, 2027, but the governor wanted it pushed back to July 1. There will be an excise tax of 6 percent on cannabis sales as well as a 5.3 percent retail sales and use tax, and municipalities will be allowed to set an additional local tax of up to 3.5 percent. Starting on July 1, 2029, the state excise tax will increase to 8 percent, in line with the governor’s previously proposed amendments. Revenue will be distributed to the Cannabis Equity Reinvestment Fund, early childhood education, the Department of Behavioral & Developmental Health Services and public health initiatives. The earlier measure passed by lawmakers would have allocated specific percentages to each, but the new language doesn’t specify what portion of revenue will go to each program. The governor, in her amendments, wanted to put all revenue into the general fund while earmarking it “for purposes such as early childhood education, behavioral health, public health awareness, prevention, treatment, and recovery services, workforce development, reentry, indigent criminal defense, and targeted reinvestment in historically disadvantaged communities.” Her amendment also sought to eliminate support for the Cannabis Equity Reinvestment Fund. The Virginia Cannabis Control Authority will oversee licensing and regulation of the new industry, and will also take on oversight of hemp, which is currently under the Department of Agriculture and Consumer Services. The body will be governed by a five-member board of directors appointed by the governor, whereas the bill previously passed by lawmakers contemplated a seven-member body with four appointed by the governor, two appointed by the speaker of the House and one appointed by the Senate Rules Committee. The definition of what constitutes a legal hemp product will be narrowed by removing a provision from current law that allows those containing more than 2 milligrams of total THC per package if they also have a ratio of CBD to THC that is 25:1 or more. Up to 350 retail marijuana stores will be allowed to be licensed to operate across the state, the same number that lawmakers had approved and greater than the 200 the governor had proposed. Local governments will not be able to opt of allowing marijuana businesses to operate in their area. Delivery services will be allowed. Serving sizes will be capped at 10 milligrams THC, with no more than 100 mg THC per package. Public use of marijuana will be a civil violation punishable by a $250 fine. That is ten times more than the $25 fine under current law, but less harsh than the class 4 criminal misdemeanor crime the governor had proposed. Possession of cannabis by people under the age of 21 will be punishable by a $25 fine and mandatory participation in a substance abuse treatment or education program or both. The governor had suggested treating underage possession as a class 1 misdemeanor, punishable with a mandatory minimum fine of $500 or 50 hours of community service, as well as the suspension of drivers licenses for at least six months. Existing medical cannabis operators can enter the adult-use market if they pay a $10 million licensing conversion fee. Cannabis businesses will have to establish labor peace agreements with workers. A legislative commission will be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. That provision was also included in the earlier legislation lawmakers passed but was suggested for deletion by the governor. Meanwhile, the governor signed several other reform bills this session—including measures to provide resentencing relief for people with past cannabis convictions, protect the parental rights of marijuana consumers and allow patients to access medical cannabis in hospitals. The post Virginia Officials Launch Marijuana Survey To Inform Drafting Of Rules For Newly Legalized Market appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The following is the perfect posting I actually found as a consequence of promote them. It's really just what exactly Needed to check out anticipation around long run you are going to continue on to get spreading this sort of great posting. AK 게임

With eight years of experience in the industry and more than 10,000 happy clients, we differentiate ourselves from other escort agencies in Delhi. Your satisfaction is our priority, letting you express your wishes for a personalized escort service experience in Delhi. Escorts in Chhatarpur || Civil Lines Escorts Service || Escorts Service Connaught Place || Escorts Service in Defence Colony || Pamposh Enclave Escorts

AMA’s new marijuana stances; Congressional psychedelics bill; NH gov candidates clash on cannabis; MO marijuana workers unionize Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Rep. Abe Hamadeh (R-AZ) and bipartisan cosponsors filed a bill to require the Department of Defense to evaluate how ongoing research on the therapeutic benefits of psilocybin could help members of the military. New Hampshire Democratic gubernatorial candidate Cinde Warmington is criticizing Gov. Kelly Ayotte’s (R) veto of a bill to allow medical cannabis companies to cultivate in greenhouses—saying it would have “made medical cannabis more affordable and more accessible to Granite Staters who really need it.” The American Medical Association’s House of Delegates adopted resolutions recognizing the therapeutic benefits and risks of marijuana use for older people and advocating a ban on flavored cannabis vapes. The American Bankers Association sent a letter urging congressional leaders to pass a marijuana banking bill—which it said is a more urgent need in light of developments surrounding the definition of legal hemp and the federal rescheduling of medical cannabis. “As a result, the volume of marijuana-related products and state-licensed proceeds is likely to increase substantially, exacerbating potential public safety and illicit finance risks.” Workers at more Missouri marijuana businesses are winning fights to unionize following a precedent-setting ruling by the National Labor Relations Board. / FEDERAL Rep. Steve Cohen (D-TN) authored an op-ed about federal marijuana rescheduling. / STATES Illinois’s lieutenant governor spoke about how social equity is central to the state’s cannabis legalization policy. A Virginia senator spoke about his opposition to the state’s new marijuana resentencing law. California regulators are accepting comments on proposed changes to rules for the cannabis appellations program. Michigan regulators published guidance about regulatory assessments for marijuana businesses. Hawaii regulators are launching a new medical cannabis patient registration site next month. Missouri regulators will soon accept applications to serve on the Cannabis Regulation Collaborative. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Los Angeles, California officials sent a monthly cannabis newsletter. / INTERNATIONAL Thai Prime Minister Anutin Charnvirakul said the nation needs to reevaluate its marijuana laws to “prevent other countries from blaming Thailand as being the weak link in this problem.” Ghana’s education minister said students who sell marijuana should be dismissed from school. / SCIENCE & HEALTH A study found that “oral CBD may reduce blood pressure amongst healthy and hypertensive individuals, particularly under stressful conditions and during sleep.” A study suggested that “cannabis can serve as a short-term coping strategy for anxiety in young adults, leading to perceived emotional regulation.” / BUSINESS Auxly Cannabis Group Inc. shareholders elected board of directors members. / CULTURE Conan O’Brien again discussed his apprehension about using cannabis gummies. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Banking group pushes Congress to pass cannabis bill (Newsletter: July 7, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This blog is so nice to me. I will keep on coming here again and again. Visit my link as well.. alexistogel

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. alexistogel login

Honestly, Wacky Steps is the standout, but all the other games are genuinely fun too. Crazy Flips 3D is thrilling in its own way, Robber Run keeps my heart racing, Ragdoll Fight makes me laugh just as much as Wacky Steps, Getaway Shootout delivers endless chaos, and Mini-Caps: Bombs challenges my brain in a different way

A major banking organization is calling on Congress to pass legislation to ease marijuana businesses’ access to financial services. The Secure and Fair Enforcement (SAFE) Banking Act would “provide important legal and regulatory clarity” and “address a significant challenge facing American businesses, our communities, and the banks that serve them,” the American Bankers Association (ABA) wrote in a letter to House of Representatives and Senate leaders. Bipartisan lawmakers in both chambers of Congress refiled the cannabis banking legislation last month—the latest development in a long-term push for the reform, which has been approved by the House several times and advanced through a Senate committee, but has yet to be enacted into law. “Although nearly every U.S. state has legalized marijuana in some form, the uncertain legal landscape governing the proceeds of these state-licensed businesses means these businesses frequently operate on a cash basis, outside the regulated banking system,” ABA’s new letter says. “These state-legal proceeds also flow to non-cannabis businesses and service providers, including accountants, skilled trades, landlords, and law firms. “The SAFE Banking Act would remove barriers to banking these funds, materially reducing the amount of cash moving through state-licensed cannabis businesses and service providers,” the group wrote. “That, in turn, would reduce the risk that these businesses are targeted by bad actors, thereby improving public safety in the communities where they operate.” Developments surrounding the legal definition of hemp and the federal rescheduling of medical marijuana “underscore the need for Congress to act” on the issue, ABA said. “As a result, the volume of marijuana-related products and state-licensed proceeds is likely to increase substantially, exacerbating potential public safety and illicit finance risks,” the letter says. “SAFE Banking would provide needed certainty by allowing these funds to enter—or remain in—the regulated banking system.” “Passing this legislation would reduce illicit finance risk and increase financial transparency for cannabis- and hemp-derived proceeds. Highly regulated banks and other financial institutions must adhere to stringent anti-money laundering and counter-terrorist financing laws and rules, conduct due diligence regarding their customers, screen transactions for suspicious activity, and keep records. Bringing these state-licensed businesses and their proceeds into the formal financial system would provide a meaningful level of transparency and accountability by enabling financial institutions to better identify and report illicit finance risk.” The letter, which is addressed to House Speaker Mike Johnson (R-LA), Senate Majority Leader John Thune (R-SD), Senate Minority Leader Chuck Schumer (D-NY) and House Minority Leader Hakeem Jeffries (D-NY), along with the chairs and ranking members of the Senate Banking Committee and House Financial Services Committee, urges that the SAFE Banking Act receive “prompt consideration” by the panels and “timely passage by Congress.” The House passed versions of the SAFE Banking Act seven times, and the Senate Banking Committee approved a cannabis banking measure in 2023 but it was not subsequently taken up on the floor and died at the end of the 118th Congress. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Sen. Tim Scott (R-SC), who currently chairs the banking panel, said recently that the fact that marijuana remains illegal at the federal level while more states legalize it has created a “quandary” for cannabis businesses and banks that wish to serve them. Even though Scott has opposed the cannabis banking reform in the past, he said that the bill would “allow for the banking question to be solved by making it legal to bank it,” Scott said. “What you don’t want is to have a situation where you have these cash rooms where you have hundreds of thousands of dollars cash sitting in a location. Everyone knows you can’t bank it and therefore the criminal activity is much higher in these places.” The post Major Banking Group Pushes Congress To Pass Bill Easing Marijuana Businesses’ Access To Financial Services appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“They basically thought it was impossible when all these companies were fighting, and now the workers are winning.” By Rebecca Rivas, Missouri Independent Missouri cannabis workers are trying to turn a string of recent union victories into broader organizing momentum across the state. High Profile Cannabis dispensary workers in Columbia last week unanimously ratified what union officials say is the state’s first collective bargaining contract for cannabis workers, securing higher pay and paid vacation time. “Now for the first time in Missouri, dispensary workers are FEELING THAT CONTRACT HIGH!” the United Food and Commercial Workers International Local 655 posted on its Facebook page Wednesday. And in St. Louis, Proper Brands post-harvest workers—who process and manufacture products—won their election to unionize last week, and Vibe Cannabis post-harvest workers are scheduled to hold an election at the end of July. “I’ve been hearing from more and more production and dispensary workers all over the state who want to find out what they need to do in order to organize their workplaces,” said Sean Shannon, organizing director at UFCW Local 655. “They basically thought it was impossible when all these companies were fighting, and now the workers are winning.” After Missouri legalized recreational marijuana in 2023, the state saw a surge in cannabis jobs that was soon followed by a push to unionize. Several groups of workers endured yearslong legal battles and company pushback. This year, some are finally seeing the results. Sierra Lutz was among the employees who organized the High-Profile union petition in 2023. She’s now a trimming tech at Vibe Cannabis, where she is leading the unionization campaign. She and her fellow post-harvest workers filed a petition to unionize last month. After hearing the news about High Profile’s contract, Lutz applauded the workers’ dedication. “I’m so proud of their perseverance,” she said. “They deserve every second of this glory.” Her work with High Profile taught her some key lessons she’s bringing to the Vibe campaign, she said. The main one: “patience is everything.” “The workplace won’t change overnight, but change will come,” Lutz said. “That’s been my biggest point I’ve been communicating to Vibe employees.” Other Vibe employees are also organizing veterans, after participating in the unionization effort at BeLeaf Medical’s Sinse cultivation facility in St. Louis. In May, Sinse workers won a significant legal precedent for post-harvest workers after nearly three-year battle, with a decision affirming their right to unionize under federal labor law. “More and more workers are feeling empowered,” Shannon said, “and I believe we’re going to see a huge wave and a rise in workers rising together.” ‘A seat at the table’ Katie Hazelwonder, a trainer in Proper’s post-harvest department, said she was overjoyed that workers voted 25-21 to unionize on July 1. “We put a lot of work into this, and I’m so thankful to everyone that stood together to make this happen,” Hazelwonder said. “That’s honestly the only way we got through this, we stood together and never backed down.” Hazelwonder acknowledged this was a stressful month for “both sides of the vote,” but said she believes the effort will result in better pay, job security and working conditions. “This victory is about all of us having a voice and having a seat at the table,” she said, “and we’re looking forward to negotiating a fair contract that reflects the hard work and dedication of everyone.” John Pennington, founder and CEO of Proper Brands, said in an email to The Independent that the company respects the post-harvest team’s decision and their right to determine how they want to be represented. “Proper Brands has always believed that our people are the foundation of our success, and that commitment remains unchanged,” Pennington said. “As we move forward, our focus will be on building a constructive relationship rooted in mutual respect, open communication, and our shared goal of producing the highest-quality cannabis products for Missouri.” Pennington also said the company remains committed to “providing a safe, supportive workplace where every team member has the opportunity to grow and contribute to our continued success.” “We are pleased to be a part of this process,” he said, “and look forward to working with the UFCW.” Hazelwonder previously told The Independent that the Proper team was encouraged by a May decision from the National Labor Relations Board, which decides labor disputes and sets national policy on union organizing. The board rejected another St. Louis marijuana company’s argument that post-harvest employees are agricultural workers, who are excluded from a federal law that protects most private-sector employees’ right to unionize without fear of retaliation. “Thanks to the recent NLRB ruling we have the opportunity to sit at the table and make it better for us and the others to come,” Hazelwonder said. Vibe At Vibe, Lutz said she and other production workers were told they’d have the federal Juneteenth holiday off this year. But then a few days before the holiday, she says managers told them they would have to work. They later learned the company paid for another department’s employees to go to Six Flags theme park on Juneteenth. It’s part of the favoritism, such as free meals and other perks, her team doesn’t get to enjoy. “I love that that department gets all of that extra stuff, like, genuinely,” Lutz said, “but our department gets absolutely nothing.” Juneteenth was the last straw for post-harvest employees who were on the fence about unionizing, Lutz said, and Shannon filed the petition to unionize on June 18. Katie Parker, human resources manager for Vibe, said the company had no comment on the petition or the issues raised by employees. Since the petition was filed, Lutz said workers have been required to meet individually with two consultants, who told employees the company hired them to educate workers on the union process. Lutz works in the trim department, where she operates the Mobius trimming machine, she said. During the summer, she said, the room is often 80 degrees with poor air circulation. “They’ve told us many times that the thing that they are worried about getting above 80 degrees in that room is not our wellbeing as employees,” she said, “but the wellbeing of the product.” She said she and her colleagues do challenging work that’s vital to the quality ofVibe’s product, but they don’t see the pay raises other departments do. Bird Herndon, who has worked in Vibe’s post-harvest department for about a year, agreed with Lutz. “Cannabis cultivation and processing are physically demanding and almost always impact respiratory health,” Herndon said. “Making sure we have consistent access to safety equipment like respirators is a top priority.” Herndon said a structured collective bargaining process would allow the team to “work collaboratively with management to formalize, streamline, and uphold high-standard safety procedures and equipment protocols for everyone.” Among the group’s demands is the option of a 401(k) so they can plan for retirement. Vibe employees have been in touch with organizers at Proper and BeLeaf, Herndon said, to learn from their experiences. “We can all help each other,” Herndon said. “More minds on the problem leads to a better solution for everyone.” This story was first published by Missouri Independent. Photo courtesy of Chris Wallis // Side Pocket Images. The post Workers At More Missouri Marijuana Businesses Win Union Fights Following Federal Ruling appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The American Medical Association (AMA) has adopted two new marijuana-related resolutions—one that advocates for a ban on flavored cannabis vaping products and another that recognizes the risks and potential therapeutic benefits of use among older adults. AMA’s House of Delegates last month approved both measures—the latest in a line of drug policy-related resolutions the body has advanced in recent years that oppose commercial marijuana legalization while backing expungement of cannabis records and supporting broad drug decriminalization, among stances on other issues. The newly adopted measure on marijuana use by older people simultaneously notes that there is a “higher incidence of dementia among individuals who use cannabis” but also that “cannabis may offer therapeutic benefits for managing agitation in dementia patients, potentially serving as an alternative to antipsychotic medications.” “Greater transparency regarding both the potential benefits and adverse effects of cannabis use in older adults would be valuable to physicians, particularly given the current paucity of research that is focused on this population,” it says. As such the measure maintains that: “RESOLVED, that our American Medical Association support the development and publication of educational resources on medical cannabis directed towards clinicians, including a virtual educational presentation that reviews the known effects of medical cannabis in older adults that highlights both its potential benefits and risks; and be it further RESOLVED, that our AMA encourage expanded research into the therapeutic uses of cannabis in older adults—such as for managing agitation in individuals with cognitive impairment—as well as its possible adverse effects.” The separate AMA-approved measure on flavored cannabis vapes argues that cannabis can have a “strong, earthy, or even bitter taste” that some users find “unpalatable” and that flavored cartridges can “mask the unpleasant taste of cannabis”—which it says have “increased adolescents’ willingness to try them.” As such, the resolution concludes that: “RESOLVED, that our American Medical Association advocate and support a complete ban on the production, marketing, and sale of Cannabis based ECIG flavored devices and cartridges throughout all regulated cannabis dispensaries (medical and adult-use) along with any outlet selling hemp products and public health entities; and be it further RESOLVED, that our AMA pursue legislative changes concerning a comprehensive ban on the production, marketing and sale of cannabis-based ECIG flavored devices and cartridges in the United States.” The newly adopted resolutions build on AMA’s existing policies taking stances on various cannabis and drug policy issues. In 2024, for example, AMA delegates adopted a resolution endorsing broad drug decriminalization. The group’s delegates in 2022 voted to amend its policy position on marijuana—which continues to oppose legalization—to support the expungement of past cannabis convictions in states that have legalized the plant. In 2023, AMA members adopted resolutions advocating for psychedelics research, opposing the criminalization of kratom, calling for an end to the sentencing disparity between crack and powder cocaine and supporting the continued inclusion of marijuana metabolites in employment-based drug tests. The post AMA Says Marijuana Has Benefits And Risks For Older Adults, While Supporting A Ban On Flavored Cannabis Vapes appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This particular is usually apparently essential and moreover outstanding truth along with for sure fair-minded and moreover admittedly useful My business is looking to find in advance designed for this specific useful stuffs… new construction homes in ave maria fl

Took me time to read all the comments, but I really enjoyed the article. It proved to be Very helpful to me and I am sure to all the commenters here! It’s always nice when you can not only be informed, but also entertained! top realtor in ave maria fl

A bipartisan group of lawmakers have filed a new bill in Congress what would require the Department of Defense to evaluate how ongoing research on the therapeutic benefits of psilocybin could help members of the military. The Veterans and Servicemembers PTSD Emerging Treatment Review Act, filed this week by Rep. Abe Hamadeh (R-AZ), would direct the assistant secretary of defense for health affairs to coordinate with other federal officials to issue a report on how the results of study on psychedelic mushrooms that is currently being carried out in Arizona could “apply to members of the Armed Forces, including such members transitioning to civilian life.” The report, due within 180 days of the legislation being enacted, would need to include “a summary of the safety, dosing, and adverse event data” from the research as well as “an assessment of the implications of such data for force health protection, medical readiness, and suicide prevention strategies.” Officials would also need to describe “legal and regulatory requirements for any potential expanded access pathway involving an investigational Schedule I substance” and provide an assessment of the applicability of the federal Right to Try law and a psychedelics executive order signed by President Donald Trump for treating PTSD during post-deployment and transition periods. The bill, which is cosponsored by Reps. Don Bacon (R-NE), Dan Crenshaw (R-TX) and Seth Moulton (D-MA), also contains a findings section that points out that existing PTSD therapies “are not effective for all patients.” “Rigorous, ethical clinical research conducted in accordance with Federal law and force health protection standards is necessary to evaluate emerging treatments for service-connected mental health conditions where existing therapies have proven insufficient,” it says. “Private-sector innovators and public-private partnerships play a central role in developing, supplying, and evaluating federally lawful investigational products used in such clinical trials.” The legislation also notes that psychedelic research underway in Arizona is “evaluating naturally derived, whole-mushroom psilocybin administered within a structured group-therapy setting for the treatment of post-traumatic stress disorder in veterans and first responders.” Hamadeh said in a press release about the new bill that “our servicemembers and veterans deserve every opportunity to access the most effective treatments backed by rigorous scientific research.” “Far too many Americans continue to struggle with treatment-resistant PTSD, contributing to suicide, substance abuse and challenges transitioning back to civilian life,” he said. “This legislation ensures Congress and the Department of Defense have the data needed to evaluate emerging research and make informed decisions that prioritize military readiness, force health and veteran care.” Sue Sisley, the researcher overseeing the Arizona-based psilocybin investigation, said Hamadeh’s staff visited her facility and “saw firsthand what these FDA clinical trials mean for veterans and first responders, and what it could mean for transitioning servicemembers in the future.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Last week week, bipartisan congressional lawmakers filed a separate bill they say is intended to codify Trump’s psychedelics executive order into law. Reps. Morgan Luttrell (R-TX), Lou Correa (D-CA), Jack Bergman (R-MI) and Michael McCaul (R-TX) introduced the Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy (IBOGAINE) Act on Tuesday. The legislation would direct the attorney general to “take all necessary steps to determine whether to transfer ibogaine and ibogaine compounds” from schedule I to schedule II of the Controlled Substances Act (CSA) within 60 days. It also says that the attorney general and the health and human services secretary would need to initiate proceedings to reschedule any other Schedule I substances that complete Phase 3 clinical trials. It would create a definition under federal law for ibogaine, to include “all parts of the plant Tabernanthe iboga” as well as any similar compound or analog that “acts on neuroplasticity, opioid receptors, or serotonergic pathways” that interrupt addiction cycles and restore neurological function disrupted by trauma, chronic substance use or traumatic brain injury. It would further codify a national priority voucher program to support development of psychedelic and other therapies that can treat widespread maladies. The legislation would additionally clarify that the federal Right to Try law provides exemptions from the CSA for seriously ill patients to access psychedelics and other Schedule I drugs in accordance with new special registration requirements it would create. The Drug Enforcement Administration (DEA) would also have to revise its quotas for the amount of a controlled substance that can be legally produced if it is rescheduled, approved by the Food and Drug Administration (FDA) or designated as a breakthrough therapy. The bill also creates a process for federal agencies to partner with states to “advance research on, and development of, psychedelic drugs, including ibogaine, for treating serious mental illnesses” as well as a framework for health agencies and the Department of Veterans Affairs (VA) to “collaborate with the private sector to increase clinical trial participation, data sharing, and real-world evidence generation regarding psychedelic drugs.” Luttrell and some of the cosponsors of the bill are also behind a proposed amendment to the National Defense Authorization Act that would extend a psychedelics research effort at the Department of Defense (DOD) for an additional six years. That proposal was cleared this week for floor action by the House Rules Committee. Shortly after Trump signed the executive order, FDA and the Department of Health and Human Services (HHS) announced steps that they say will help with “accelerating” therapeutic access to psychedelics for patients dealing with serious mental health conditions. Health and Human Services Secretary Robert F. Kennedy Jr. said recently that the Trump administration is “very anxious” to create a pathway for access to psychedelics therapy and that top officials across federal agencies want to “get it out to the public as quickly as possible.” In an interview on the Joe Rogan Experience in February, Kennedy said he’s confident “we’re going to get it done,” with plans to develop and finalize rules that would enable patients with conditions such as post-traumatic stress disorder (PTSD) and depression to access psychedelic substances like psilocybin and MDMA in a “very controlled setting.” “Everybody in my agency…is very anxious to get a rule out there that will allow these kind of studies and will allow access under therapeutic settings, particularly [for] the military soldiers who have suffered these injuries to get access to these products,” the HHS secretary said. “We’re working through that process now. We’re all working on it and trying to make it happen.” “I think that we’re going to get it done,” he said. Last June, Kennedy said his agency is “absolutely committed” to expanding research on the benefits of psychedelic therapy and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans “within 12 months.” Veterans Affairs Secretary Doug Collins also disclosed in April that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he said he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access. Bipartisan congressional lawmakers introduced legislation this session to provide $30 million in funding annually to establish psychedelic-focused “centers for excellence” at U.S. Department of Veterans Affairs (VA) facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine. A U.S. Senate committee held a hearing in April on a bipartisan bill to promote research into the therapeutic potential psychedelics by creating a new office at VA that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugs like psilocybin, ibogaine and MDMA. Read the full psilocybin bill below: The post Defense Department Would Issue Report On How Psychedelic Mushrooms Can Benefit Military Members Under New Congressional Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A New Hampshire Democratic gubernatorial candidate is criticizing the incumbent Republican governor for vetoing a bill to let medical cannabis companies grow marijuana in greenhouses. Supporters say the proposal will make cannabis more affordable and available for patients, and it passed the Senate and House of Representatives in voice votes this session—but Gov. Kelly Ayotte (R) vetoed it last month. “Come on, Kelly. Shouldn’t we be trying to make health care more affordable for Granite Staters, not less?” Cinde Warmington, the sole Democrat running for her party’s nomination to challenge Ayotte in November, said in a video posted to social media. “This bill would have made medical cannabis more affordable and more accessible to Granite Staters who really need it, and she vetoed it,” Warmington said. “But honestly, this is what we’ve come to expect from Kelly Ayotte. Look what she did to the Medicaid premiums. She increased them by up to $270 a month on the most vulnerable Granite Staters. She increased prescription co-pays when other costs are already going through the roof.” “New Hampshire deserves a governor who will fight to make sure we have lower health care costs and that health care is more accessible,” the Democratic candidate, who previously served as a member of the New Hampshire Executive Council, said. “That’s the bottom line.” Making medical cannabis more expensive for Granite Staters? Come on, Kelly. #NHPolitics pic.twitter.com/OWfoQspFQi — Cinde Warmington (@CindeWarmington) June 24, 2026 In a veto statement on the medical marijuana greenhouse bill, the governor simply said, “I do not support expanding the cultivation of marijuana in our state.” Meanwhile, New Hampshire lawmakers and advocates are pushing to override Ayotte’s veto. “I disagree with the governor’s decision to veto SB 468,” Sen. Howard Pearl (R), the lead sponsor of the legislation, told Marijuana Moment last month. “This bipartisan bill would have provided a practical way to lower costs for patients with serious medical conditions while maintaining the rigorous oversight and safeguards that have made New Hampshire’s Therapeutic Cannabis Program successful.” “At a time when affordability remains a significant challenge for many families, we should be looking for responsible ways to expand access to treatment and ease financial burdens,” he said. Sen. Tara Reardon (D) similarly said she is “disappointed” in the governor’s action, which she said will result in “denying cost-saving measures for more than 17,000 veterans and patients across New Hampshire who rely on medical cannabis as an important component of their physician-recommended care.” “I hope my Senate colleagues will join me in voting to override the veto and pass the bill into law,” she told Marijuana Moment. The legislation says that “each alternative treatment center registered under this section may request authorization to operate a greenhouse cultivation location, at the same or at a different location than its existing cultivation location, in order to reduce energy costs and provide lower prices for registered qualifying patients.” The only person to testify against the bill this session was a former state lawmaker who now serves as chair of the prohibitionist organization Smart Approaches to Marijuana NH. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Ayotte has separately threatened to veto any marijuana legalization bill that reaches her desk. The governor said last year that her position on the reform would not change even as the federal government moved forward with rescheduling the plant. In 2024, then-Gov. Chris Sununu (R) vetoed a similar proposal to allow cannabis businesses to cultivate in greenhouses. The House had enough votes to override that action, but the Senate did not. Photo courtesy of Chris Wallis // Side Pocket Images. The post New Hampshire Democratic Challenger Slams GOP Governor’s Veto Of Medical Marijuana Greenhouse Cultivation Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Awesome article! I want people to know just how good this information is in your article. It’s interesting, compelling content. Your views are much like my own concerning this subject. 인디고 게임

her in fact awesome blog page. her realy content rich and then a this fantastic profession. i prefer this unique. bandar togel

Succeed! It could be one of the most useful blogs we have ever come across on the subject. Excellent info! I’m also an expert in this topic so I can understand your effort very well. Thanks for the huge help. 성인피시 This blog website is pretty cool! How was it made ! 성인피시